Chrysostomi Gialeli
1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Evaluation of Glycosaminoglycans Biological Age in Cells and Tissues
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression
(
- Contribution to journal › Article
- 2022
-
Mark
Expression of cartilage oligomeric matrix protein in periampullary adenocarcinoma is associated with pancreatobiliary-type morphology, higher levels of fibrosis and immune cell exclusion
(
- Contribution to journal › Article
- 2021
-
Mark
Extracellular matrix: paving the way to the newest trends in atherosclerosis
(
- Contribution to journal › Article
-
Mark
Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
(
- Contribution to journal › Article
- 2019
-
Mark
Cartilage Oligomeric Matrix Protein initiates cancer stem cells through activation of Jagged1-Notch3 signaling
(
- Contribution to journal › Article
- 2018
-
Mark
Novel potential inhibitors of complement system and their roles in complement regulation and beyond
(
- Contribution to journal › Article
- 2016
-
Mark
Emerging aspects of nanotoxicology in health and disease: From agriculture and food sector to cancer therapeutics.
2016) In Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 91(May). p.42-57(
- Contribution to journal › Scientific review
-
Mark
Synthesis and antiproliferative activity of two diastereomeric lignan amides serving as dimeric caffeic acid-l-DOPA hybrids
(
- Contribution to journal › Article
-
Mark
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
(
- Contribution to journal › Article